{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T11:22:01Z","timestamp":1785410521127,"version":"3.56.0"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T00:00:00Z","timestamp":1683590400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p>Encouraged by randomized controlled trials demonstrating non-inferiority of transfemoral transcatheter aortic valve implantation (TAVI) compared to surgical aortic valve replacement (SAVR) across all surgical risk categories, there has been a dramatic increase in the use of TAVI in a younger patient cohort with severe aortic stenosis, endorsed by both European and American Cardiac Societies. However, the standard use of TAVI in younger, less co-morbid patients with a longer life expectancy can only be supported if there is sound data demonstrating long-term durability of transcatheter aortic valves (TAVs). In this article, we have reviewed available randomized and observational registry clinical data pertaining to TAV long-term durability, placing emphasis on trials and registries using the new standardized definitions of bioprosthetic valve dysfunction (BVD) and bioprosthetic valve failure (BVF). Despite inherent difficulties in interpreting the available data, the determination reached is that the risk of structural valve deterioration (SVD) is potentially lower after TAVI than SAVR at 5 to 10 years, and that the two treatment modalities have a similar risk of BVF. This supports the adoption of TAVI in younger patients evident in current practice. However, the routine use of TAVI in younger patients with bicuspid aortic valve stenosis should be cautioned due to insufficient long-term TAV durability data in this particular patient population. Finally, we highlight the importance of future research into the unique potential mechanisms that can potentially contribute to TAV degeneration.<\/jats:p>","DOI":"10.3389\/fcvm.2023.1195397","type":"journal-article","created":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T20:50:38Z","timestamp":1683751838000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":16,"title":["Transcatheter aortic valve durability: a contemporary clinical review"],"prefix":"10.3389","volume":"10","author":[{"given":"Nicholas J.","family":"Montarello","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yannick","family":"Willemen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Tirado-Conte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Travieso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gintautas","family":"Bieliauskas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Sondergaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ole","family":"De Backer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,5,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1056\/NEJMoa1008232","article-title":"Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery","volume":"363","author":"Leon","year":"2010","journal-title":"N Engl J Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1056\/NEJMoa1103510","article-title":"Transcatheter versus surgical aortic-valve replacement in high-risk patients","volume":"364","author":"Smith","year":"2011","journal-title":"N Engl J Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1056\/NEJMoa1514616","article-title":"Transcatheter or surgical aortic-valve replacement in intermediate-risk patients","volume":"374","author":"Leon","year":"2016","journal-title":"N Engl J Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1056\/NEJMoa1700456","article-title":"Surgical or transcatheter aortic-valve replacement in intermediate-risk patients","volume":"376","author":"Reardon","year":"2017","journal-title":"N Engl J Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1056\/NEJMoa1814052","article-title":"Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients","volume":"380","author":"Mack","year":"2019","journal-title":"N Engl J Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1056\/NEJMoa1816885","article-title":"Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients","volume":"380","author":"Popma","year":"2019","journal-title":"N Engl J Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1093\/ejcts\/ezab389","article-title":"2021 ESC\/EACTS Guidelines for the management of valvular heart disease: developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS).","volume":"60","author":"Vahanian","year":"2021","journal-title":"Eur J Cardiothorac Surg"},{"key":"B8","doi-asserted-by":"publisher","first-page":"e72","DOI":"10.1161\/CIR.0000000000000923","article-title":"2020 ACC\/AHA guideline for the management of patients with valvular heart disease: a report of the American college of cardiology\/American heart association joint committee on clinical practice guidelines.","volume":"143","author":"Otto","year":"2021","journal-title":"Circulation"},{"key":"B9","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.athoracsur.2014.09.030","article-title":"Very long-term outcomes of the carpentier-edwards perimount valve in aortic position","volume":"99","author":"Bourguignon","year":"2015","journal-title":"Ann Thorac Surg"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1016\/j.athoracsur.2014.10.070","article-title":"Long-term durability of bioprosthetic aortic valves: implications from 12,569 implants","volume":"99","author":"Johnston","year":"2015","journal-title":"Ann Thorac Surg"},{"key":"B11","doi-asserted-by":"publisher","first-page":"136","DOI":"10.4070\/kcj.2021.0223","article-title":"Pericardial versus porcine valves for surgical aortic valve replacement","volume":"52","author":"Shin","year":"2022","journal-title":"Korean Circ J"},{"key":"B12","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1001\/jamacardio.2018.4045","article-title":"Durability data for bioprosthetic surgical aortic valve: a systematic review","volume":"4","author":"Fatima","year":"2019","journal-title":"JAMA Cardiol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1016\/j.jtcvs.2013.07.005","article-title":"Long-term results of the medtronic mosaic porcine bioprosthesis in the aortic position","volume":"147","author":"Anselmi","year":"2014","journal-title":"J Thorac Cardiovasc Surg"},{"key":"B14","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1093\/ejcts\/ezx244","article-title":"Standardized definitions of structural deterioration and valve failure in assessing long-term durability of transcatheter and surgical aortic bioprosthetic valves: a consensus statement from the European association of percutaneous cardiovascular interventions (EAPCI) endorsed by the European society of cardiology (ESC) and the European association for cardio-thoracic surgery (EACTS)","volume":"52","author":"Capodanno","year":"2017","journal-title":"Eur J Cardiothorac Surg"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1016\/j.jacc.2020.08.049","article-title":"Structural deterioration of transcatheter versus surgical aortic valve bioprostheses in the PARTNER-2 trial","volume":"76","author":"Pibarot","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.1093\/eurheartj\/ehaa799","article-title":"Valve academic research consortium 3: updated endpoint definitions for aortic valve clinical research","volume":"77","author":"VARC-3","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1016\/S0140-6736(15)60308-7","article-title":"5-year Outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial","volume":"385","author":"Mack","year":"2015","journal-title":"Lancet"},{"key":"B18","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1016\/S0140-6736(15)60290-2","article-title":"5-year Outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial","volume":"385","author":"Kapadia","year":"2015","journal-title":"Lancet"},{"key":"B19","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jcmg.2016.11.004","article-title":"Long-Term valve performance of TAVR and SAVR: a report from the PARTNER I trial","volume":"10","author":"Daubert","year":"2016","journal-title":"JACC Cardiovasc Imaging"},{"key":"B20","doi-asserted-by":"publisher","first-page":"2687","DOI":"10.1016\/j.jacc.2018.08.2146","article-title":"5-Year Outcomes of self-expanding transcatheter versus surgical aortic valve replacement in high-risk patients","volume":"72","author":"Gleason","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"B21","year":""},{"key":"B22","doi-asserted-by":"publisher","first-page":"2714","DOI":"10.1161\/CIRCULATIONAHA.118.036606","article-title":"Five-Year clinical and echocardiographic outcomes from the nordic aortic valve intervention (NOTION) randomized clinical trial in lower surgical risk patients","volume":"139","author":"Thyregod","year":"2019","journal-title":"Circulation"},{"key":"B23","doi-asserted-by":"publisher","first-page":"2597","DOI":"10.1161\/CIRCULATIONAHA.118.036866","article-title":"Five-Year clinical outcome and valve durability after transcatheter aortic valve replacement in high-risk patients","volume":"138","author":"Didier","year":"2018","journal-title":"Circulation"},{"key":"B24","doi-asserted-by":"publisher","first-page":"996","DOI":"10.4244\/EIJ-D-22-00493","article-title":"Life expectancy of patients with a transcatheter aortic valve and the implications for long-term valve durability data collection","volume":"18","author":"Vanhaverbeke","year":"2023","journal-title":"EuroIntervention"},{"key":"B25","doi-asserted-by":"publisher","first-page":"2912","DOI":"10.1093\/eurheartj\/ehab375","article-title":"Eight-year outcomes for patients with aortic valve stenosis at low surgical risk randomized to transcatheter vs. Surgical aortic valve replacement","volume":"42","author":"Jorgensen","year":"2021","journal-title":"Eur Heart J"},{"key":"B26","doi-asserted-by":"publisher","first-page":"41","DOI":"10.4244\/EIJ-D-17-00603","article-title":"Beyond the five-year horizon: long-term outcome of high-risk and inoperable patients undergoing TAVR with first-generation devices","volume":"14","author":"Deutsch","year":"2018","journal-title":"EuroIntervention"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e008440","DOI":"10.1161\/JAHA.117.008440","article-title":"Incidence of long-term structural valve dysfunction and bioprosthetic valve failure after transcatheter aortic valve replacement","volume":"7","author":"Barbanti","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"B28","doi-asserted-by":"publisher","first-page":"e264","DOI":"10.4244\/EIJ-D-18-00015","article-title":"Assessment of structural valve deterioration of transcatheter aortic bioprosthetic balloon-expandable valves using the new European consensus definition","volume":"14","author":"Eltchaninoff","year":"2018","journal-title":"EuroIntervention"},{"key":"B29","doi-asserted-by":"publisher","first-page":"e390","DOI":"10.4244\/EIJ-D-18-00041","article-title":"Long-term durability and haemodynamic performance of a self-expanding transcatheter heart valve beyond five years after implantation: a prospective observational study applying the standardised definitions of structural deterioration and valve failure","volume":"14","author":"Holy","year":"2018","journal-title":"EuroIntervention"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1093\/eurheartj\/ehz925","article-title":"Long-term clinical outcome and performance of transcatheter aortic valve replacement with a self-expandable bioprosthesis","volume":"41","author":"Testa","year":"2020","journal-title":"Eur Heart J"},{"key":"B31","doi-asserted-by":"publisher","first-page":"E431","DOI":"10.1002\/ccd.28804","article-title":"Ten year follow-up of high-risk patients treated during the early experience with transcatheter aortic valve replacement","volume":"97","author":"Sathananthan","year":"2021","journal-title":"Catheter Cardiovasc Interv"},{"key":"B32","doi-asserted-by":"publisher","first-page":"s2","DOI":"10.1136\/heartjnl-2018-313510","article-title":"UK TAVI registry","volume":"105","author":"Ludman","year":"2019","journal-title":"Heart"},{"key":"B33","doi-asserted-by":"publisher","first-page":"e35","DOI":"10.1161\/CIR.0000000000000923","article-title":"2020 ACC\/AHA guideline for the management of patients with valvular heart disease: executive summary: a report of the American college of cardiology\/American heart association joint committee on clinical practice guidelines","volume":"143","author":"Otto","year":"2021","journal-title":"Circulation"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1016\/j.jacc.2016.12.006","article-title":"2017 ACC expert consensus decision pathway for transcatheter aortic valve replacement in the management of adults with aortic stenosis: a report of the American college of cardiology task force on clinical expert consensus documents","volume":"69","author":"Otto","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/j.jcin.2019.12.026","article-title":"5-Year Outcomes after TAVR with balloon-expandable versus self-expanding valves: results from the CHOICE randomized clinical trial","volume":"13","author":"Abdel-Wahab","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1093\/eurheartj\/ehaa036","article-title":"Comparison of newer generation self-expandable vs. Balloon-expandable valves in transcatheter aortic valve implantation: the randomized SOLVE-TAVI trial","volume":"41","author":"Thiele","year":"2020","journal-title":"Eur Heart J"},{"key":"B37","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.jcin.2022.11.032","article-title":"5-Year Outcomes with self-expanding vs balloon-expandable transcatheter aortic valve replacement in patients with small annuli","volume":"16","author":"Okuno","year":"2023","journal-title":"JACC Cardiovasc Interv"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.4244\/EIJ-D-18-00779","article-title":"Long-term results and durability of the CoreValve transcatheter aortic bioprosthesis: outcomes beyond five years","volume":"14","author":"Panico","year":"2019","journal-title":"EuroIntervention"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2023.1195397\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T20:50:42Z","timestamp":1683751842000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2023.1195397\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,9]]},"references-count":38,"alternative-id":["10.3389\/fcvm.2023.1195397"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2023.1195397","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,9]]},"article-number":"1195397"}}